# PPIP5K2

## Overview
PPIP5K2 is a gene that encodes the protein diphosphoinositol pentakisphosphate kinase 2, a member of the ATP-grasp kinase family. This protein plays a pivotal role in cellular signaling by regulating the synthesis and degradation of inositol pyrophosphates, which are critical for various cellular processes such as endocytosis, vesicle trafficking, apoptosis, and DNA repair (An2019Dynamics; Yousaf2018Mutations). The PPIP5K2 protein is characterized by its unique structural features, including an ATP-grasp fold and a secondary ligand-binding site that enhances substrate capture (Wang2014Synthetic; Wang2011Structural). It is active in both the cytoplasm and nucleus, with its localization being regulated by nuclear localization signals and phosphorylation events (Yong2015Identification). Mutations in the PPIP5K2 gene have been linked to clinical conditions such as familial keratoconus and hearing loss, highlighting its significance in maintaining cellular and physiological functions (Khaled2019PPIP5K2; Yousaf2018Mutations). Additionally, PPIP5K2 is implicated in cancer biology, particularly in non-small cell lung cancer, where it is overexpressed and contributes to tumor progression (Yang2024PPIP5K2).

## Structure
The PPIP5K2 protein is a member of the ATP-grasp kinase family, characterized by its unique structural features. The kinase domain of PPIP5K2, spanning residues 37-366 or 41-366, exhibits an ATP-grasp fold, with the nucleotide positioned between two sets of antiparallel β-sheets (Wang2011Structural). The N terminus forms an αβα domain, contributing to the core catalytic structure. The enzyme's active site is composed of key residues, including arginine and lysine, which form a specific binding pocket for inositol pyrophosphate substrates (Wang2011Structural).

PPIP5K2 also features a secondary ligand-binding site, distinct from the catalytic site, which aids in substrate capture. This site is located near the entrance to the catalytic center and is involved in enhancing substrate capture from the bulk phase (Wang2014Synthetic). The structural dynamics of PPIP5K2 involve a 'catch-and-pass' mechanism, where substrates are transferred from the capture site to the catalytic site, facilitated by specific residues such as Glu192 (An2019Dynamics).

The enzyme's structure is further stabilized by interactions with Mg2+ ions, which are crucial for its catalytic activity (An2019Dynamics). The PPIP5K2 protein may undergo post-translational modifications, such as phosphorylation, influencing its activity and interactions.

## Function
PPIP5K2, or diphosphoinositol pentakisphosphate kinase 2, is an enzyme that plays a critical role in the synthesis and regulation of inositol pyrophosphates, which are important signaling molecules in cellular processes. In healthy human cells, PPIP5K2 is involved in the phosphorylation of 5-IP7 to form 1,5-IP8, and it can also catalyze the reverse reaction, dephosphorylating 1,5-IP8 back to 5-IP7. This balance is crucial for maintaining cellular phosphate homeostasis and is involved in processes such as endocytosis, vesicle trafficking, apoptosis, and DNA repair (An2019Dynamics; Yousaf2018Mutations).

PPIP5K2 is active in both the cytoplasm and the nucleus, with its nuclear localization being regulated by a nuclear localization signal (NLS) and phosphorylation events. The enzyme's nuclear translocation is significant for its function, as it helps regulate the activity of inositol pyrophosphates by preventing non-specific interactions and competition with other inositol phosphates (Yong2015Identification).

The enzyme's activity is also linked to hearing, as mutations in PPIP5K2 can lead to hearing loss due to the degeneration of cochlear outer hair cells. This highlights the enzyme's importance in maintaining hair cell function and inner ear health (Yousaf2018Mutations).

## Clinical Significance
Mutations in the PPIP5K2 gene have been associated with several clinical conditions, most notably familial keratoconus and hearing loss. In the context of keratoconus, a corneal disorder characterized by thinning and structural changes of the cornea, variants such as S419A and N843S in the PPIP5K2 gene have been identified. These variants affect the balance of phosphatase and kinase activities, leading to increased synthesis of inositol pyrophosphates, which are implicated in the pathogenesis of keratoconus (Khaled2019PPIP5K2). Mouse models with mutations in PPIP5K2 exhibit corneal abnormalities similar to those seen in keratoconus, including corneal opacification and abnormal curvature (Akoto2024Identification).

PPIP5K2 mutations are also linked to autosomal recessive nonsyndromic hearing loss, specifically DFNB100-deafness. The R837H variant in the phosphatase domain of PPIP5K2 reduces phosphatase activity, leading to an imbalance in kinase activity and accumulation of inositol pyrophosphates, which are crucial for cellular signaling. This imbalance is associated with degeneration of cochlear outer hair cells and progressive hearing loss (Yousaf2018Mutations).

In non-small cell lung cancer (NSCLC), PPIP5K2 is overexpressed and facilitates tumor proliferation and metastasis through the AKT/mTOR signaling pathway, suggesting its role as an oncogene in this context (Yang2024PPIP5K2).

## Interactions
PPIP5K2 interacts with various proteins that influence its localization and function. It has been shown to interact with importin-5 and importin-8, which are part of the β-importin family. These interactions facilitate the nuclear translocation of PPIP5K2, as demonstrated by its higher nuclear-to-cytosol fluorescence ratio compared to its paralog PPIP5K1 (Yong2015Identification). The nuclear localization of PPIP5K2 is also influenced by a penta-Arginine sequence, which contributes to its nuclear import, and phosphorylation of an adjacent serine residue may modulate this process (Yong2015Identification).

PPIP5K2 is involved in the synthesis of diphosphoinositol polyphosphates, which are regulatory molecules in cell signaling. The protein's kinase domain interacts with synthetic inositol phosphate analogs, which can stimulate its ATPase activity. This interaction is facilitated by a unique substrate capture site distinct from the catalytic site, allowing for potential selective drug targeting (Wang2014Synthetic). The R213A mutation in PPIP5K2 impairs substrate occupation of this capture site, affecting ATPase activity, highlighting the importance of specific amino acid residues in its interactions (Wang2014Synthetic). These interactions suggest that PPIP5K2 plays a significant role in cellular signaling pathways and may be a target for therapeutic interventions.


## References


[1. (Khaled2019PPIP5K2) Mariam Lofty Khaled, Yelena Bykhovskaya, Chunfang Gu, Alice Liu, Michelle D. Drewry, Zhong Chen, Barbara A. Mysona, Emily Parker, Ryan P. McNabb, Hongfang Yu, Xiaowen Lu, Jing Wang, Xiaohui Li, Abdulrahman Al-Muammar, Jerome I. Rotter, Louise F. Porter, Amy Estes, Mitchell A. Watsky, Sylvia B. Smith, Hongyan Xu, Khaled K. Abu-Amero, Anthony Kuo, Stephen B. Shears, Yaron S. Rabinowitz, and Yutao Liu. Ppip5k2 and pcsk1 are candidate genetic contributors to familial keratoconus. Scientific Reports, December 2019. URL: http://dx.doi.org/10.1038/s41598-019-55866-5, doi:10.1038/s41598-019-55866-5. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-55866-5)

[2. (Yousaf2018Mutations) Rizwan Yousaf, Chunfang Gu, Zubair M. Ahmed, Shaheen N. Khan, Thomas B. Friedman, Sheikh Riazuddin, Stephen B. Shears, and Saima Riazuddin. Mutations in diphosphoinositol-pentakisphosphate kinase ppip5k2 are associated with hearing loss in human and mouse. PLOS Genetics, 14(3):e1007297, March 2018. URL: http://dx.doi.org/10.1371/journal.pgen.1007297, doi:10.1371/journal.pgen.1007297. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007297)

[3. (An2019Dynamics) Yi An, Henning J. Jessen, Huanchen Wang, Stephen B. Shears, and Dmitri Kireev. Dynamics of substrate processing by ppip5k2, a versatile catalytic machine. Structure, 27(6):1022-1028.e2, June 2019. URL: http://dx.doi.org/10.1016/j.str.2019.03.007, doi:10.1016/j.str.2019.03.007. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2019.03.007)

[4. (Wang2014Synthetic) Huanchen Wang, Himali Y. Godage, Andrew M. Riley, Jeremy D. Weaver, Stephen B. Shears, and Barry V.L. Potter. Synthetic inositol phosphate analogs reveal that ppip5k2 has a surface-mounted substrate capture site that is a target for drug discovery. Chemistry &amp; Biology, 21(5):689–699, May 2014. URL: http://dx.doi.org/10.1016/j.chembiol.2014.03.009, doi:10.1016/j.chembiol.2014.03.009. This article has 49 citations.](https://doi.org/10.1016/j.chembiol.2014.03.009)

[5. (Yong2015Identification) Sheila T. Yong, Hoai-Nghia Nguyen, Jae H. Choi, Carl D. Bortner, Jason Williams, Niyas K. Pulloor, Manoj N. Krishnan, and Stephen B. Shears. Identification of a functional nuclear translocation sequence in hppip5k2. BMC Cell Biology, June 2015. URL: http://dx.doi.org/10.1186/s12860-015-0063-7, doi:10.1186/s12860-015-0063-7. This article has 14 citations.](https://doi.org/10.1186/s12860-015-0063-7)

[6. (Yang2024PPIP5K2) Qi Yang, Chenhui Cao, Binghuo Wu, Haochi Yang, Tian Tan, Dan Shang, Chuan Xu, and Xiaoyi Huang. Ppip5k2 facilitates proliferation and metastasis of non-small lung cancer (nsclc) through akt signaling pathway. Cancers, 16(3):590, January 2024. URL: http://dx.doi.org/10.3390/cancers16030590, doi:10.3390/cancers16030590. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16030590)

[7. (Akoto2024Identification) Theresa Akoto, Rachel Hadvina, Skyler Jones, Jingwen Cai, Hongfang Yu, Hayden McCord, Charles X. J. Jin, Amy J. Estes, Lin Gan, Anthony Kuo, Sylvia B. Smith, and Yutao Liu. Identification of keratoconus-related phenotypes in three ppip5k2 mouse models. Investigative Ophthalmology &amp; Visual Science, 65(6):22, June 2024. URL: http://dx.doi.org/10.1167/iovs.65.6.22, doi:10.1167/iovs.65.6.22. This article has 0 citations.](https://doi.org/10.1167/iovs.65.6.22)

[8. (Wang2011Structural) Huanchen Wang, J R Falck, Traci M Tanaka Hall, and Stephen B Shears. Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding. Nature Chemical Biology, 8(1):111–116, November 2011. URL: http://dx.doi.org/10.1038/nchembio.733, doi:10.1038/nchembio.733. This article has 115 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nchembio.733)